Press Releases

SILVER SPRING, Md., Aug. 28, 2019 /PRNewswire/ -- Protecting patients is the FDA's highest priority, and Americans can be confident in the quality of the products the agency approves. The recent Angiotensin II Receptor Blocker (ARB) recalls have deeply concerned patients, the medical community, the agency and international regulatory bodies. The FDA is aware m

NEW YORK, Aug. 28, 2019 /PRNewswire/ -- The American Journal of Kidney Diseases (AJKD) will publish today an article summarizing the deliberations and recommendations from a

RYE BROOK, N.Y., Aug. 28, 2019 /PRNewswire/ -- Blood Cancer Awareness Month in September provides an opportunity to remind the public about the urgent need to support research to find cures, and The Leukemia & Lymphoma Society (LLS) is marking the occasion with a reinvigorated focus on helping children with cancer live better, longer lives.Experience the

IOWA CITY, Iowa, Aug. 28, 2019 /PRNewswire/ -- iotaMotion, Inc., a medical device startup spun out from the University of Iowa's Otolaryngology Department, announced today that the company has raised an additional $2.52 million in a second round of funding. The Company is focused on achieving development and

SCOTTSDALE, Ariz., Aug. 28, 2019 /PRNewswire/ -- sweetFrog® (www.sweetfrog.com) will join the fight for the health of all moms and babies with its month-long nationwide in-store fundra

GRAND JUNCTION, Colo., Aug. 28, 2019 /PRNewswire/ -- EcoGen Laboratories, the leading vertically-integrated manufacturer and supplier of hemp-derived specialty ingredients in

BOSTON, Aug. 28, 2019 /PRNewswire/ -- National telehealth leader American Well® announced today a new offering within 

BIRMINGHAM, England, Aug. 28, 2019 /PRNewswire/ -- Scientists at the University of Birmingham have created an antimicrobial coating for steel surfaces which has proven to rapidly kill bacteria that cause some of the most common hospital-acquired infections.

THOUSAND OAKS, Calif., Aug. 28, 2019 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the presentation of 14 cardiovascular scientific research abstracts, including studies evaluating the safety and efficacy of Repatha® (evolocumab) by race and ethnicity and further examining its clinical benefit in patients with familial hypercholesterolemia (FH

RISHIKESH, India, Aug. 28, 2019 /PRNewswire/ --  HEMPCORP envisions a green future and aims to provide global consumers with the best alternative organic medicine available by utilising hemp sourced cannabinoids and terpenes.